Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(16)
Опубликована: Март 12, 2024
Abstract
Cancer
stem
cells
(CSCs)
are
essential
for
tumor
initiation,
recurrence,
metastasis,
and
resistance.
However,
targeting
CSCs
as
a
therapeutic
approach
remains
challenging.
Here,
stemness
signature
based
on
22‐gene
is
developed
to
predict
prognosis
in
esophageal
squamous
cell
carcinoma
(ESCC).
Staurosporine
(STS)
identified
radioresistance
suppressor
by
high‐throughput
screening
of
library
2131
natural
compounds,
leading
dramatically
improved
radiotherapy
efficacy
subcutaneous
models.
Mechanistically,
STS
inhibits
proliferation
through
the
mTOR/AKT
signaling
pathway
suppressed
ATP‐binding
cassette
A1
(ABCA1),
which
transcriptionally
regulated
liver
X
receptor
alpha
(LXRα).
can
selectively
bind
nucleotide‐binding
domain
(NBD)
ABCA1
compete
ATP,
blocking
ABCA1‐mediated
drug
efflux
facilitating
intracellular
accumulation
STS.
Considering
cytotoxicity
STS,
an
extracellular
vesicle‐encapsulated
system
(EV‐STS)
established
effective
delivery.
EV‐STS
shows
remarkable
growth
inhibition,
even
at
half
dose
with
superior
safety
efficacy.
These
findings
indicate
that
may
serve
predictor
response
neoadjuvant
chemotherapy
and/or
ESCC
patients.
has
shown
antitumor
low
systemic
toxicity,
offering
promising
ESCC.
Cancers,
Год журнала:
2023,
Номер
15(1), С. 318 - 318
Опубликована: Янв. 3, 2023
Cancer-derived
exosomes
exhibit
sophisticated
functions,
such
as
proliferation,
apoptosis,
migration,
resistance,
and
tumor
microenvironment
changes.
Several
clinical
drugs
modulate
these
exosome
but
the
impacts
of
natural
products
are
not
well
understood.
Exosome
functions
regulated
by
processing,
secretion
assembly.
The
modulation
exosome-processing
genes
can
exert
anticancer
precancer
effects
cancer-derived
exosomes.
This
review
focuses
on
exosomal
miRNAs
that
regulate
acting
natural-product-modulating
cell
cancer
cells.
However,
role
processing
has
been
overlooked
in
several
studies
products.
In
this
study,
utilizing
bioinformatics
database
(miRDB),
natural-product-modulated
were
predicted.
Consequently,
described
here.
sheds
light
improves
our
understanding
modulating
their
potential
targets
treatments
based
use
Pharmaceutics,
Год журнала:
2023,
Номер
15(7), С. 1902 - 1902
Опубликована: Июль 7, 2023
Extracellular
vesicles
(EVs)
are
small,
membrane-based
released
by
cells
that
play
a
critical
role
in
various
physiological
and
pathological
processes.
They
act
as
vehicles
for
transporting
variety
of
endogenous
cargo
molecules,
enabling
intercellular
communication.
Due
to
their
natural
properties,
EVs
have
emerged
promising
“cell-free
therapy”
strategy
treating
diseases,
including
cancer.
serve
excellent
carriers
different
therapeutics,
nucleic
acids,
proteins,
small
other
nanomaterials.
Modifying
or
engineering
can
improve
the
efficacy,
targeting,
specificity,
biocompatibility
EV-based
therapeutics
cancer
therapy.
In
this
review,
we
comprehensively
outline
biogenesis,
isolation,
methodologies
EVs,
well
biological
functions.
We
then
focus
on
specific
applications
drug
therapy
citing
prominent
recent
studies.
Additionally,
discuss
opportunities
challenges
using
pharmaceutical
delivery
vehicles.
Ultimately,
aim
provide
theoretical
technical
support
development
treatment.
Theranostics,
Год журнала:
2024,
Номер
14(10), С. 4161 - 4183
Опубликована: Янв. 1, 2024
Extracellular
vesicles
(EVs)
are
enclosed
by
a
nanoscale
phospholipid
bilayer
membrane
and
typically
range
in
size
from
30
to
200
nm.They
contain
high
concentration
of
specific
proteins,
nucleic
acids,
lipids,
reflecting
but
not
identical
the
composition
parent
cell.The
inherent
characteristics
variety
EVs
give
them
extensive
unique
advantages
field
cancer
identification
treatment.Recently,
have
been
recognized
as
potential
tumor
markers
for
detection
cancer.Aptamers,
which
molecules
single-stranded
DNA
or
RNA,
demonstrate
remarkable
specificity
affinity
their
targets
adopting
distinct
tertiary
structures.Aptamers
offer
various
over
protein
counterparts,
such
reduced
immunogenicity,
ability
convenient
large-scale
synthesis,
straightforward
chemical
modification.In
this
review,
we
summarized
biogenesis,
sample
collection,
isolation,
storage
characterization,
finally
provided
comprehensive
survey
analysis
techniques
that
based
on
aptamers.
Macromolecular Bioscience,
Год журнала:
2024,
Номер
24(6)
Опубликована: Янв. 24, 2024
Hydrogels
are
3D
networks
swollen
with
water.
They
biocompatible,
strong,
and
moldable
emerging
as
a
promising
biomedical
material
for
regenerative
medicine
tissue
engineering
to
deliver
therapeutic
genes.
The
excellent
natural
extracellular
matrix
simulation
properties
of
hydrogels
enable
them
be
co-cultured
cells
or
enhance
the
expression
viral
non-viral
vectors.
Its
biocompatibility,
high
strength,
degradation
performance
also
make
action
process
carriers
in
tissues
more
ideal,
making
it
an
ideal
material.
It
has
been
shown
that
hydrogel-based
gene
delivery
technologies
have
potential
play
therapy-relevant
roles
organs
such
bone,
cartilage,
nerve,
skin,
reproductive
organs,
liver
animal
experiments
preclinical
trials.
This
paper
reviews
recent
articles
on
explains
manufacture,
applications,
developmental
timeline,
limitations,
future
directions
techniques.
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(16)
Опубликована: Март 12, 2024
Abstract
Cancer
stem
cells
(CSCs)
are
essential
for
tumor
initiation,
recurrence,
metastasis,
and
resistance.
However,
targeting
CSCs
as
a
therapeutic
approach
remains
challenging.
Here,
stemness
signature
based
on
22‐gene
is
developed
to
predict
prognosis
in
esophageal
squamous
cell
carcinoma
(ESCC).
Staurosporine
(STS)
identified
radioresistance
suppressor
by
high‐throughput
screening
of
library
2131
natural
compounds,
leading
dramatically
improved
radiotherapy
efficacy
subcutaneous
models.
Mechanistically,
STS
inhibits
proliferation
through
the
mTOR/AKT
signaling
pathway
suppressed
ATP‐binding
cassette
A1
(ABCA1),
which
transcriptionally
regulated
liver
X
receptor
alpha
(LXRα).
can
selectively
bind
nucleotide‐binding
domain
(NBD)
ABCA1
compete
ATP,
blocking
ABCA1‐mediated
drug
efflux
facilitating
intracellular
accumulation
STS.
Considering
cytotoxicity
STS,
an
extracellular
vesicle‐encapsulated
system
(EV‐STS)
established
effective
delivery.
EV‐STS
shows
remarkable
growth
inhibition,
even
at
half
dose
with
superior
safety
efficacy.
These
findings
indicate
that
may
serve
predictor
response
neoadjuvant
chemotherapy
and/or
ESCC
patients.
has
shown
antitumor
low
systemic
toxicity,
offering
promising
ESCC.